News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
837,150 Results
Type
Article (85982)
Company Profile (649)
Press Release (750519)
Section
Business (232165)
Career Advice (4124)
Deals (39703)
Drug Delivery (125)
Drug Development (90769)
Employer Resources (198)
FDA (17975)
Job Trends (17310)
News (395443)
Policy (39642)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2984)
Academic (1)
Accelerated approval (3)
Adcomms (25)
Allergies (76)
Alliances (56612)
ALS (74)
Alzheimer's disease (1449)
Antibody-drug conjugate (ADC) (127)
Approvals (17966)
Artificial intelligence (207)
Autoimmune disease (21)
Automation (10)
Bankruptcy (401)
Best Places to Work (12511)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (447)
Bladder cancer (59)
Brain cancer (25)
Breast cancer (208)
Cancer (1814)
Cardiovascular disease (132)
Career advice (3527)
Career pathing (33)
CAR-T (149)
Cell therapy (421)
Cervical cancer (17)
Clinical research (72607)
Collaboration (721)
Compensation (383)
Complete response letters (28)
COVID-19 (2822)
CRISPR (40)
C-suite (197)
Cystic fibrosis (97)
Data (1684)
Decentralized trials (2)
Denatured (43)
Depression (35)
Diabetes (175)
Diagnostics (6736)
Digital health (8)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (109)
Drug pricing (91)
Drug shortages (17)
Duchenne muscular dystrophy (75)
Earnings (95113)
Editorial (33)
Employer branding (25)
Employer resources (167)
Events (127975)
Executive appointments (552)
FDA (18838)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (595)
Gene editing (93)
Generative AI (21)
Gene therapy (296)
GLP-1 (719)
Government (5076)
Grass and pollen (4)
Guidances (33)
Healthcare (20741)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (115)
Indications (22)
Infectious disease (2928)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (40)
Intellectual property (79)
Interviews (812)
IPO (17674)
IRA (38)
Job creations (5183)
Job search strategy (2861)
Kidney cancer (10)
Labor market (37)
Layoffs (527)
Leadership (19)
Legal (10049)
Liver cancer (69)
Lung cancer (267)
Lymphoma (119)
Machine learning (3)
Management (65)
Manufacturing (257)
MASH (63)
Medical device (14288)
Medtech (14293)
Mergers & acquisitions (22238)
Metabolic disorders (560)
Multiple sclerosis (68)
NASH (22)
Neurodegenerative disease (91)
Neuropsychiatric disorders (23)
Neuroscience (1900)
NextGen: Class of 2025 (7666)
Non-profit (5054)
Northern California (2142)
Now hiring (38)
Obesity (301)
Opinion (267)
Ovarian cancer (68)
Pain (62)
Pancreatic cancer (56)
Parkinson's disease (119)
Partnered (18)
Patents (175)
Patient recruitment (81)
Peanut (48)
People (64730)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22426)
Phase II (31571)
Phase III (23739)
Pipeline (926)
Podcasts (122)
Policy (114)
Postmarket research (3542)
Preclinical (10073)
Press Release (72)
Prostate cancer (78)
Psychedelics (34)
Radiopharmaceuticals (249)
Rare diseases (340)
Real estate (7378)
Recruiting (75)
Regulatory (26329)
Reports (55)
Research institute (2645)
Resumes & cover letters (649)
Rett syndrome (1)
RNA editing (4)
RSV (32)
Schizophrenia (66)
Series A (117)
Series B (68)
Service/supplier (25)
Sickle cell disease (45)
Southern California (1845)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (33)
Startups (4281)
State (2)
Stomach cancer (11)
Supply chain (44)
The Weekly (77)
United States (18564)
Vaccines (709)
Venture capitalists (36)
Webinars (13)
Weight loss (221)
Women's health (35)
Worklife (18)
Date
Today (121)
Last 7 days (620)
Last 30 days (2316)
Last 365 days (30331)
2025 (6799)
2024 (34029)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (50)
Alaska (6)
Arizona (239)
Arkansas (8)
Asia (49733)
Australia (8782)
California (4877)
Canada (1483)
China (453)
Colorado (156)
Connecticut (200)
Delaware (116)
Europe (113773)
Florida (602)
Georgia (138)
Hawaii (1)
Idaho (64)
Illinois (425)
India (23)
Indiana (257)
Iowa (9)
Japan (120)
Kansas (107)
Kentucky (16)
Louisiana (7)
Maine (58)
Maryland (798)
Massachusetts (3882)
Michigan (177)
Minnesota (301)
Mississippi (1)
Missouri (51)
Montana (24)
Nebraska (26)
Nevada (50)
New Hampshire (50)
New Jersey (1408)
New Mexico (27)
New York (1391)
North Carolina (964)
North Dakota (7)
Northern California (2142)
Ohio (157)
Oklahoma (13)
Oregon (44)
Pennsylvania (1042)
Puerto Rico (9)
Rhode Island (21)
South America (1647)
South Carolina (4)
South Dakota (1)
Southern California (1845)
Tennessee (30)
Texas (649)
Utah (109)
Virginia (92)
Washington D.C. (36)
Washington State (482)
West Virginia (1)
Wisconsin (36)
837,150 Results for "takara bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership
Jumpcode Genomics and Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the companies have settled their patent dispute and have partnered to bring together their combined foundational IP in the field of targeted depletion of undesired transcripts such as ribosomal RNAs from NGS libraries using CRISPR-based technology.
June 13, 2024
·
3 min read
Biotech Bay
Takara Bio Launches First Commercial Dissolvable Microfluidic Lentiviral Transduction Enhancer
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable microfluidic transduction enhancer that innovates in vitro lentivirus-mediated gene delivery techniques.
May 6, 2024
·
3 min read
Press Releases
Takara Bio USA Holdings, Inc. Announces the Acquisition of Curio Bioscience, Adding Spatial Biology to Its Broad Portfolio of Single-Cell Omics Solutions
January 16, 2025
·
3 min read
Biotech Bay
Takara Bio transforms single-cell landscape with new large-scale NGS profiling system for oncology biomarker discovery
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Shasta™ Single-Cell System, an automated, high-throughput NGS solution with well-validated chemistries and intuitive bioinformatics tools that enables novel biomarker discovery for oncology research.
April 2, 2024
·
4 min read
Press Releases
Takara Bio Launches High-Throughput, Cost-Effective qPCR System to Advance Clinical Research
November 20, 2024
·
3 min read
Biotech Bay
Takara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics’ NGS Library Enrichment Patent
Takara Bio USA, Inc. announced that it has once again prevailed in its second patent dispute with Jumpcode Genomics, Inc.
December 11, 2023
·
2 min read
Biotech Bay
Takara Bio’s First-to-Market Large-Scale Single-Cell NGS Profiling Technologies Poised to Revolutionize Biomarker Discovery
Takara Bio USA, Inc. today announced plans to launch two critical solutions for oncology research. These automated single-cell total RNA-seq and DNA-seq library preparation kits will provide high sample and cell throughput, less hands-on time, and the ability to capture more information than other available technologies.
February 5, 2024
·
3 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Business
Takara Bio USA, Inc. and BioExcel Diagnostics Partner for Development of Wide-Coverage Infectious Disease Detection Panels
Takara Bio USA, Inc., a pioneering life science reagent and instrument company and wholly owned subsidiary of Takara Bio Inc., is partnering with BioExcel Diagnostics to develop and validate a new high-throughput and comprehensive method for detecting syndromic-based infectious diseases.
October 17, 2022
·
4 min read
1 of 83,715
Next